<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6789597\results\search\drugs\results.xml">
  <result pre="rashes, and fluids to prevent dehydration in ZIKV-infected patients. However," exact="acetylsalicylic acid" post="and non-steroidal anti-inflammatory drugs (NSAIDs) are contraindicated because of"/>
  <result pre="in pre-clinical evaluation, this drug was dismissed [55]. The prodrug" exact="sofosbuvir" post="is a nucleoside analog that is a RdRp inhibitor"/>
  <result pre="commercially available for the treatment of chronic HCV infection. The" exact="sofosbuvir" post="phosphoramidate prodrug is converted to its triphosphate analog in"/>
  <result pre="inhibitory activity in Vero cells. Therefore, the inhibitory activity of" exact="sofosbuvir" post="varied among different cell types [58]. Interestingly, sequence analysis"/>
  <result pre="sequence analysis of ZIKV isolated from infected cells treated with" exact="sofosbuvir" post="showed higher frequency of mutations compared with untreated cells"/>
  <result pre="receptor 1 (IFN-αR1) blocking antibody [60], therapeutic oral administration of" exact="sofosbuvir" post="with a physiologically relevant dose of 33 mg/kg/day for"/>
  <result pre="toxicity [57]. Importantly, in clinical phase II and III studies," exact="sofosbuvir" post="was found to be clinically safe and efficacious in"/>
  <result pre="men and non-pregnant women to prevent tissue damage. BCX4430, an" exact="adenosine" post="nucleoside analog, is a selective inhibitor of the viral"/>
  <result pre="ZIKV methyltransferase in complex with the pan-methyltransferase inhibitor sinefungin, an" exact="adenosine" post="derivative, originally isolated from Streptomyces griseoleus as a potential"/>
  <result pre="five flavonoids (myricetin, quercetin, luteolin, isorhamnetin, apigenin) and one natural" exact="phenol" post="(curcumin) which were shown to inhibit Zika NS2B-NS3 protease"/>
  <result pre="severe histopathological changes than untreated controls [77]. NS3 helicases display" exact="adenosine" post="triphosphatase (ATPase) and RNA triphosphatase (RTPase) activities. NS3 inhibitors"/>
  <result pre="to explain ribavirin’s antiviral properties including indirect mechanisms such as" exact="inosine" post="monophosphate dehydrogenase inhibition (IMPDH) and immunomodulatory effects as well"/>
  <result pre="infections. Our group and others demonstrated the inhibitory activity of" exact="ribavirin" post="against ZIKV strains of different geographic origins in several"/>
  <result pre="Recent studies have shown that merimepodib (MMPD or VX-497) and" exact="mycophenolic acid" post="(MPA), two IMPDH inhibitors, also inhibit ZIKV-RNA replication in"/>
  <result pre="assay (EC50 = 20.7 μM) [93]. The antiflaviviral activity of" exact="lovastatin" post="was also demonstrated against HCV and DENV [94,95]. In"/>
  <result pre="et al., demonstrated that a short-term parenteral course of high-dose" exact="lovastatin" post="in mice markedly attenuated nervous system injury and, thus,"/>
  <result pre="values of 9.82, 14.2, and 12.36 μM, respectively. In addition," exact="chloroquine" post="was able to partially reverse morphological changes induced by"/>
  <result pre="changes induced by ZIKV in mouse neurospheres [101]. In vitro," exact="chloroquine" post="reduces the number of ZIKV-infected cells, and inhibits virus"/>
  <result pre="multiple neural cell types or inhibit ZIKV replication. Among them," exact="seliciclib" post="(a purine analog) and RGB-286147 inhibited ZIKV infection at"/>
  <result pre="to treat Alzheimer disease such as memantine, MK-801, agmatine, and" exact="ifenprodil" post="were found to prevent neuronal cell death caused by"/>
  <result pre="ameliorate neuronal symptoms during infection. Costa et al. showed that" exact="memantine" post="was very effective at preventing ZIKV-induced neuronal cell death"/>
  <result pre="ZIKV-induced neuronal cell death and neurodegeneration in IFN-α/βR−/−mice [106]. Importantly," exact="memantine" post="is also listed in pregnancy category B drugs by"/>
  <result pre="women and fetus. The World Health Organization (WHO) recommends that" exact="niclosamide" post="may be used during pregnancy as an anthelminthic agent"/>
  <result pre="individual patients in clinical settings, the risk of treatment with" exact="niclosamide" post="in pregnant women who are known to have an"/>
  <result pre="disease progression in the absence of treatment�? (http://www.cdc.gov/parasites/hymenolepis/health_professionals/). In addition," exact="niclosamide" post="and other direct- or indirect-acting agents could be used"/>
  <result pre="al.Inhibition of dengue virus by an ester prodrug of an" exact="adenosine" post="analogAntimicrob. Agents Chemother.2010543255326110.1128/AAC.00397-1020516277 50.FurutaY.TakahashiK.ShirakiK.SakamotoK.SmeeD.F.BarnardD.L.GowenB.B.JulanderJ.G.MorreyJ.D.T-705 (favipiravir) and related compounds: Novel"/>
  <result pre="efficacy against Zika infectionInt. J. Infect. Dis.201755293010.1016/j.ijid.2016.12.01127988410 57.Bullard-FeibelmanK.M.GoveroJ.ZhuZ.SalazarV.VeselinovicM.DiamondM.S.GeissB.J.The FDA-approved drug" exact="sofosbuvir" post="inhibits Zika virus infectionAntivir. Res.201713713414010.1016/j.antiviral.2016.11.02327902933 58.SacramentoC.Q.de MeloG.R.de FreitasC.S.RochaN.HoelzL.V.MirandaM.Fintelman-RodriguesN.MarttorelliA.FerreiraA.C.Barbosa-LimaG.et al.The"/>
  <result pre="infectionAntivir. Res.201713713414010.1016/j.antiviral.2016.11.02327902933 58.SacramentoC.Q.de MeloG.R.de FreitasC.S.RochaN.HoelzL.V.MirandaM.Fintelman-RodriguesN.MarttorelliA.FerreiraA.C.Barbosa-LimaG.et al.The clinically approved antiviral drug" exact="sofosbuvir" post="inhibits Zika virus replicationSci. Rep.201774092010.1038/srep4092028098253 59.PeralesC.DomingoE.Antiviral Strategies Based on"/>
  <result pre="III studiesDig. Liver Dis.201446Suppl. 5S179S18510.1016/j.dld.2014.09.02625458780 62.EyerL.ZouharovaD.SirmarovaJ.FojtikovaM.StefanikM.HaviernikJ.NenckaR.de ClercqE.RuzekD.Antiviral activity of the" exact="adenosine" post="analogue BCX4430 against West Nile virus and tick-borne flavivirusesAntivir."/>
  <result pre="86.BekermanE.EinavS.Infectious disease. Combating emerging viral threatsScience201534828228310.1126/science.aaa377825883340 87.GraciJ.D.CameronC.E.Mechanisms of action of" exact="ribavirin" post="against distinct virusesRev. Med. Virol.200616374810.1002/rmv.48316287208 88.SidwellR.W.HuffmanJ.H.KhareG.P.AllenL.B.WitkowskiJ.T.RobinsR.K.Broad-spectrum antiviral activity of"/>
  <result pre="macrolides during pregnancyAm. J. Obstet Gynecol.2013208221.e1221.e810.1016/j.ajog.2012.12.02323254249 99.Al-BariM.A.A.Targeting endosomal acidification by" exact="chloroquine" post="analogs as a promising strategy for the treatment of"/>
  <result pre="Causes Placental Damage and Fetal DemiseCell20161651081109110.1016/j.cell.2016.05.00827180225 103.KuivanenS.BespalovM.M.NandaniaJ.IanevskiA.VelagapudiV.De BrabanderJ.K.KainovD.E.VapalahtiO.Obatoclax, saliphenylhalamide and" exact="gemcitabine" post="inhibit Zika virus infection in vitro and differentially affect"/>
  <result pre="isorhamnetin, apigenin, curcumin NS2B-NS3 protease inhibitor √ X Niclosamide, and" exact="nitazoxanide" post="NS2B-NS3 protease inhibitor √ X Temoporfin NS2B-NS3 protease inhibitor"/>
  <result pre="Several mechanisms including purine synthesis inhibitor √ √ Merimepodib and" exact="mycophenolic acid" post="Inosine monophosphate dehydrogenase (IMPDH) inhibitors √ X Azathioprine Purine"/>
  <result pre="inhibitor √ X 6-azauridine, 5-fluorouracil Pirimidine synthesis inhibitor √ X" exact="lovastatin" post="HMG-CoA reductase inhibitor √ X Azithromycin Unknown mechanisms of"/>
  <result pre="X PHA-690509 Cyclin-dependent kinase inhibitor √ X MK-801, agmatine, and" exact="ifenprodil" post="Neuronal cell death inhibitor √ X Memantine Neuronal cell"/>
 </snippets>
</snippetsTree>
